Picture of Medtronic logo

MDT — Medtronic Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+1.16%
3m+12.56%
6m+11.2%
1yr-13.32%
Volume Change (%)
10d/3m-30.33%
Price vs... (%)
52w High-22.33%
50d MA-1.7%
200d MA-7.11%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)18.12
PEG Ratio (f)6.56
EPS Growth (f)2.84%
Dividend Yield (f)2.51%
Valuation (ttm)IndustryMarket
Price to Book Value2.69
Price to Tang. Bookn/a
Price to Free Cashflow24.94
Price to Sales4.45
EV to EBITDA18.56

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital6.86%
Return on Equity9.57%
Operating Margin17.89%

Financial Summary

Year End 30th AprUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m29,71029,95330,55728,91330,11732,032.8333,286.660.88%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+21.65+11.3+12.76-4.18-13.87+59.12+2.97n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for MDT

The Medtronic share price – where next? background image

The Medtronic share price – where next?

The Medtronic (NYQ:MDT) share price has risen by 2.63% over the past month and it’s currently trading at 104.77. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue...

Upbeat broker recommendations for Medtronic background image

Upbeat broker recommendations for Medtronic

The Medtronic (NYQ:MDT) share price has risen by 1.77% over the past month and it’s currently trading at 95.55. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue....

Will the Medtronic share price run continue? background image

Will the Medtronic share price run continue?

In this article we will quickly re-cap the broker forecasts for Medtronic (NYQ:MDT). The Medtronic share price has risen by 2.07% over the past month and it’s currently trading at 96.97. For investors considering whether to buy, hold o...

Upbeat broker recommendations for Medtronic background image

Upbeat broker recommendations for Medtronic

The Medtronic (NYQ:MDT) share price has risen by 13.5% over the past month and it’s currently trading at 96.76. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue....

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Apr 202230th Apr 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Medtronic EPS forecast chart

Profile Summary

Medtronic plc is a global healthcare technology company. It develops, manufactures, and markets its medical devices and technologies to hospitals, physicians, clinicians, and patients. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes. Cardiovascular products include pacemakers, insertable cardiac monitors, and cardiac resynchronization therapy devices. Medical Surgical products include patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. Neuroscience products include various spinal implants, bone graft substitutes, biologic products, image-guided surgery and intra-operative imaging systems. Diabetes products include insulin pumps, continuous glucose monitoring (CGM) systems, consumables, and smart insulin pen systems. The Company also provides PROPEL and SINUVA, which is bioabsorbable, steroid-eluting implants for sinus patients.

Directors

Last Annual
April 30th, 2021
Last Interim
January 28th, 2022
Incorporated
June 12th, 2014
Public Since
March 17th, 1980
No. of Employees
90,000
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
1,341,539,178

MDT Share Price Performance

Similar to MDT

Picture of Abbott Laboratories logo

Abbott Laboratories

us flag iconNew York Stock Exchange

Picture of Agilent Technologies logo

Agilent Technologies

us flag iconNew York Stock Exchange

Picture of Agiliti logo

Agiliti

us flag iconNew York Stock Exchange

Picture of Alcon AG logo

Alcon AG

us flag iconNew York Stock Exchange

Picture of AmerisourceBergen logo

AmerisourceBergen

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email